Cleared Traditional

K200484 - CARTO® 3 EP Navigation System with Signal Processing Unit

K200484 is an FDA 510(k) clearance for CARTO 3 EP Navigation System with Signa..., manufactured by Biosense Webster, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 272-day FDA review.

K200484 · Biosense Webster, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
272d
Days
Class 2
Risk

K200484 is an FDA 510(k) clearance for the CARTO® 3 EP Navigation System with Signal Processing Unit. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Biosense Webster, Inc. (Irvin, US). The FDA issued a Cleared decision on November 25, 2020 after a review of 272 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biosense Webster, Inc. devices

FDA 510(k) Submission Details - K200484

510(k) Number K200484 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 2020
Decision Date November 25, 2020
Days to Decision 272 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
147d slower than avg
Panel avg: 125d · This submission: 272d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 359
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K200484.
AltaTrack equipment, AltaTrack Guidewire, AltaTrack Catheter
K201081 · Philips Medical System Nederland B.V. · Dec 2020
Graffiti
K202189 · Ge Medical Systems Information Technologies, Inc. · Dec 2020
AcQMap High Resolution Imaging and Mapping System
K201015 · Acutus Medical, Inc. · Dec 2020
EnSite X EP System, Advisor VL Circular Mapping Catheter, Sensor Enabled, Advisor FL Circular Mapping Catheter, Sensor Enabled, Advisor HD Grid High Density Mapping Catheter, Senor Enabled
K202066 · Abbott Medical · Nov 2020
Cordiana Dx16
K201060 · Cordiana Medical Informatics AG · Nov 2020
CoroFlow Cardiovascular System
K201881 · Coroventis Research AB · Nov 2020